Literature DB >> 20351751

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.

S Laechelt1, E Turrini, A Ruehmkorf, W Siegmund, I Cascorbi, S Haenisch.   

Abstract

ABCC2 (MRP2) is an important export pump, expressed at tissue barriers. The genetic variants -24C>T, 1249G>A and 3972C>T are leading to inter-individual differences of bioavailability of various endogenous and exogenous compounds. Considering ABCC2 haplotypes, we investigated DNA-protein binding properties, mRNA secondary structure, mRNA stability, protein expression and transport activity in various cell lines and analyzed the bioavailability of talinolol in 24 healthy Caucasian volunteers; -24C>T had no clear influence on DNA-protein binding and the mRNA stability did not differ significantly. In transfected HEK293T/17 cells, haplotypes H9 (CGT), H10 (TGC) and H12 (TGT) had significantly lower protein expression, whereas H2 (CAC) exhibited significantly increased protein expression compared to the wild type (H1, CGC): 32.7 ± 8.8, 73.1 ± 6.3; 44.0 ± 15.5 and 115.2 ± 8.2%, respectively. This corresponded with efflux rates of the fluorescent dye glutathione-methylfluorescein in vitro and by trend with talinolol bioavailability in vivo. In conclusion our results show a haplotype-dependent influence on transport capacity of ABCC2, which seems to be mainly based on posttranscriptional modification of protein expression rather than transport rates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351751     DOI: 10.1038/tpj.2010.20

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  23 in total

1.  In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.

Authors:  Xia Wen; Melanie S Joy; Lauren M Aleksunes
Journal:  Pharm Res       Date:  2017-04-12       Impact factor: 4.200

2.  Multigene predictors of tacrolimus exposure in kidney transplant recipients.

Authors:  Rebecca A Pulk; David S Schladt; William S Oetting; Weihua Guan; Ajay K Israni; Arthur J Matas; Rory P Remmel; Pamala A Jacobson
Journal:  Pharmacogenomics       Date:  2015-06-12       Impact factor: 2.533

3.  Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype.

Authors:  T Vanhove; P Annaert; D Lambrechts; D R J Kuypers
Journal:  Pharmacogenomics J       Date:  2016-07-05       Impact factor: 3.550

Review 4.  Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Authors:  Camille Tron; Florian Lemaitre; Céline Verstuyft; Antoine Petitcollin; Marie-Clémence Verdier; Eric Bellissant
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

5.  Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2.

Authors:  Lenka Slachtova; Ondrej Seda; Jana Behunova; Martin Mistrik; Pavel Martasek
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

6.  Effect of ABCC2 (MRP2) transport function on erythromycin metabolism.

Authors:  R M Franke; C S Lancaster; C J Peer; A A Gibson; A M Kosloske; S J Orwick; R H Mathijssen; W D Figg; S D Baker; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2011-03-30       Impact factor: 6.875

7.  Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.

Authors:  Zaipul I Md Dom; Janet K Coller; Robert P Carroll; Jonathan Tuke; Brett C McWhinney; Andrew A Somogyi; Benedetta C Sallustio
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

8.  Neuropsychiatric manifestations associated with azithromycin in two brothers.

Authors:  Elad Schiff; K May; L H Goldstein
Journal:  Eur J Clin Pharmacol       Date:  2010-09-22       Impact factor: 2.953

Review 9.  The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.

Authors:  Pin Chen; Qing Yan; Haitao Xu; Ailin Lu; Peng Zhao
Journal:  Genet Test Mol Biomarkers       Date:  2013-12-10

10.  Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Authors:  Isabelle Benz-de Bretagne; Noël Zahr; Amélie Le Gouge; Jean-Sébastien Hulot; Caroline Houillier; Khe Hoang-Xuan; Emmanuel Gyan; Séverine Lissandre; Sylvain Choquet; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.